Type to search

Muna Therapeutics Launches with US$ 73M Series A to Advance Novel Small Molecule Therapeutics for Neurodegenerative Diseases | Pharmtech Focus
Roche’s ENSPRYNG Approved by European Commission as First and Only At-home Subcutaneous Treatment for Neuromyelitis Optica Spectrum Disorder (NMOSD) | Pharmtech Focus
Kesimpta® (Ofatumumab) Data Show Long-term Preservation of IgG/IgM Levels and no Increased Risk of Serious Infections in People Living with Multiple Sclerosis | Pharmtech Focus